Ceftriaxone

Lyme Polyradiculitis, Chancroid, Whipple Disease + 33 more
Treatment
24 FDA approvals
20 Active Studies for Ceftriaxone

What is Ceftriaxone

CeftriaxoneThe Generic name of this drug
Treatment SummaryCeftriaxone is an antibiotic used to treat a wide range of bacterial infections. It is a third-generation cephalosporin that has a long half-life, which means it can be taken once or twice a day. It is especially effective against multi-drug resistant bacteria and has a relatively low risk of side effects. Ceftriaxone is better at fighting Gram-negative bacteria compared to other cephalosporin antibiotics, but it is not as effective against Staphylococcus aureus.
Rocephinis the brand name
image of different drug pills on a surface
Ceftriaxone Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Rocephin
Ceftriaxone
1993
165

Approved as Treatment by the FDA

Ceftriaxone, commonly known as Rocephin, is approved by the FDA for 24 uses including Gonorrhea and Bacterial Infections .
Gonorrhea
Bacterial Infections
bacterial otitis media
Sepsis Bacterial
Abdominal Infection
Lower respiratory tract infection bacterial
Skin and Subcutaneous Tissue Bacterial Infections
Bone and Joint Infections
prophylaxis of Postoperative Infections
uncomplicated Urinary tract infection bacterial
uncomplicated Gonorrhea
complicated Bacterial Urinary Tract Infections
Urinary Tract Infection (UTI)
Meningitis, Bacterial
Bacterial Infections
Sepsis
Osteomyelitis
Intraabdominal Infections
Urinary Tract Infections
Urinary Tract Infections
Postoperative Infections
Bacteria
Otitis Media
Pelvic Inflammatory Disease

Effectiveness

How Ceftriaxone Affects PatientsCeftriaxone is an antibiotic used to treat bacterial infections that are usually caused by certain types of bacteria. It works by stopping the growth of bacteria and is resistant to many different types of enzymes that bacteria can produce. When taking ceftriaxone, it should not be mixed with any liquids that contain calcium, as it can cause the drug to turn into a solid. Taking ceftriaxone can also lead to a buildup of small stones in the gallbladder or bile duct.
How Ceftriaxone works in the bodyCeftriaxone stops the growth of bacterial cells by blocking the formation of protective walls around them. It does this by stopping certain enzymes in the bacterial cell membrane from working properly, which prevents the cell wall from forming. Without this wall, the bacteria are unable to survive and die off.

When to interrupt dosage

The endorsed dose of Ceftriaxone is contingent upon the diagnosed condition, including Otitis Media, Conjunctivitis and Sepsis Bacterial. The quantity of dosage also fluctuates based upon the administration strategy (e.g. Powder, for solution or Solution) featured in the table beneath.
Condition
Dosage
Administration
Pelvic Inflammatory Disease
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Arthritis, Infectious
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Community Acquired Pneumonia (CAP)
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Lyme Polyradiculitis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Sinusitis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Epiglottitis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Epididymitis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Bacteria
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Vulvovaginitis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Urinary Tract Infections
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Sepsis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Syphilis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Urinary Tract Infections
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Intraabdominal Infections
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Shigellosis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Gonorrhea
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Conjunctivitis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
prophylaxis of Bacterial endocarditis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Gonococcal arthritis
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical
Neisseria
100.0 mg/mL, , 2000.0 mg, 500.0 mg, 250.0 mg, 200.0 mg/mL, 1000.0 mg, 10000.0 mg, 100000.0 mg
, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular, Injection, powder, for solution - Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Kit - Intramuscular; Intravenous, Kit, Kit - Intramuscular; Intravenous; Topical, Intramuscular; Intravenous; Topical

Warnings

Ceftriaxone Contraindications
Condition
Risk Level
Notes
Hyperbilirubinemia
Do Not Combine
calcium-containing IV solution requirement
Do Not Combine
There are 20 known major drug interactions with Ceftriaxone.
Common Ceftriaxone Drug Interactions
Drug Name
Risk Level
Description
Neomycin
Major
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Neomycin.
Tenofovir
Major
Ceftriaxone may increase the nephrotoxic activities of Tenofovir.
Tenofovir alafenamide
Major
Ceftriaxone may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir disoproxil
Major
Ceftriaxone may increase the nephrotoxic activities of Tenofovir disoproxil.
Vibrio cholerae CVD 103-HgR strain live antigen
Major
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceftriaxone.
Ceftriaxone Toxicity & Overdose RiskTaking too much ceftriaxone may increase the chances of developing kidney stones, which can lead to kidney failure. Other symptoms of overdose are not known, but may be similar to the side effects of the drug. If a ceftriaxone overdose occurs, supportive treatment should be given as dialysis will not remove the drug from the body.
image of a doctor in a lab doing drug, clinical research

Ceftriaxone Novel Uses: Which Conditions Have a Clinical Trial Featuring Ceftriaxone?

12 active trials are underway to examine the potential of Ceftriaxone in treating Postoperative Infections, uncomplicated Bacterial Urinary Tract Infections and Whipple Disease.
Condition
Clinical Trials
Trial Phases
Whipple Disease
0 Actively Recruiting
Sinusitis
0 Actively Recruiting
Prosthetic Joint Infections
2 Actively Recruiting
Phase 4, Not Applicable
Epididymitis
0 Actively Recruiting
Postoperative Infections
0 Actively Recruiting
Abscess
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Intraabdominal Infections
1 Actively Recruiting
Not Applicable
Meningitis, Bacterial
0 Actively Recruiting
Otitis Media
0 Actively Recruiting
Urinary Tract Infections
0 Actively Recruiting
Community Acquired Pneumonia (CAP)
5 Actively Recruiting
Not Applicable, Phase 1, Phase 3
Gonorrhea
0 Actively Recruiting
Bacterial Infections
0 Actively Recruiting
Neisseria
0 Actively Recruiting
Arthritis, Infectious
0 Actively Recruiting
Urinary Tract Infection (UTI)
6 Actively Recruiting
Phase 1, Phase 3, Phase 4, Phase 2
prophylaxis of Postoperative Infections
0 Actively Recruiting
Osteomyelitis
0 Actively Recruiting
Vulvovaginitis
0 Actively Recruiting

Ceftriaxone Reviews: What are patients saying about Ceftriaxone?

5Patient Review
1/27/2008
Ceftriaxone for Middle Ear Infection
This was a lifesaver when my twins both had double ear infections. The amoxicillin didn't work, so our doctor gave them each a shot. They slept great that night and were back to their normal selves the next day. So much easier than having to remember to give them medicine multiple times a day for 10 days!
5Patient Review
11/29/2007
Ceftriaxone for Bone Infection caused by Staphylococcus Aureus Bacteria
I developed a serious infection after two failed surgeries to correct my pectus excavatum. My surgeon had to place metal plates in my chest and the wound was weeping fluids for weeks. I started weekly injections of cefatriaxone and things went very well. The wound healed in just a few days and I was back to normal within a week.
4Patient Review
5/11/2009
Ceftriaxone for Bacterial Meningitis
A single 2 gm dose really helped me out and eased my condition within a night.
4Patient Review
9/15/2017
Ceftriaxone for Lyme Disease
I had recurrant Lyme disease which oral antibiotics like Doxycycline and Tetracycline couldn't help. After a month of getting medicine through an arm cath though, I was feeling much better. I was more tired than before and needed lots of sleep, but it was worth finally getting rid of the Lyme. There are some lasting side effects from chronic Lyme, but this treatment did its job.
2.3Patient Review
2/11/2012
Ceftriaxone for Urinary Tract Infection due to E. Coli Bacteria
I've had chronic UTIs for years now and haven't found a medication that really works. I've been to many doctors, both in Florida and Michigan, and no one has been able to help me.
1Patient Review
3/27/2008
Ceftriaxone for Bacterial Pneumonia caused by Staphylococcus
Worked well for me.
1Patient Review
10/11/2009
Ceftriaxone for Pneumonia caused by Bacteria
I had an allergic reaction to this medication that started in mid-August and is still ongoing as of this writing. My skin was covered with a "cobblestone appearance" and severe redness and itching. After two months, the condition is still present. Additionally, it has been difficult to walk and handle objects comfortably. I would never recommend this product for anyone.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ceftriaxone

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug ceftriaxone used for?

"Ceftriaxone is used to treat bacterial infections in many different parts of the body. It is also given before certain types of surgery to prevent infections. Ceftriaxone belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth."

Answered by AI

What bacteria is killed by ceftriaxone?

"Ceftriaxone not only eliminates some of the primary agents of respiratory tract infections, but also common hospital superbugs. This makes it a powerful tool in the fight against these diseases."

Answered by AI

Is ceftriaxone a strong antibiotic?

"Ceftriaxone (Rocephin) is a strong antibiotic that works against a good number of bacteria, but there are other antibiotics that can treat more types of infections or more serious infections."

Answered by AI

Is ceftriaxone a penicillin drug?

"Ceftriaxone is an antibiotic that can be used to treat various types of bacterial infections. This includes infections in the lower respiratory tract, skin, urinary tract, pelvic region, blood, and joints. Additionally, it can be used to treat bacterial meningitis."

Answered by AI

Clinical Trials for Ceftriaxone

Image of Children's Healthcare of Atlanta in Atlanta, United States.

Antibiotic Strategies for Pneumonia in Children

12 - 71
All Sexes
Atlanta, GA
The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are: * To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy. Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other. Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.
Recruiting
Has No Placebo
Children's Healthcare of Atlanta (+3 Sites)Todd Florin, MD, MSCE
Have you considered Ceftriaxone clinical trials? We made a collection of clinical trials featuring Ceftriaxone, we think they might fit your search criteria.Go to Trials
Image of Maternity Centre of Hamilton in Hamilton, Canada.

Rapid Test for Syphilis

13 - 49
All Sexes
Hamilton, Canada
The goal of this clinical trial is to learn if a finger-prick blood test for rapid diagnosis of syphilis infection can be implemented in a low-barrier prenatal clinic for people at risk of syphilis in pregnancy. The test gives results in 5 minutes and also tests for HIV. The main questions the study aims to answer are: * How often do pregnant people at risk of syphilis agree to the rapid test? * How well do healthcare providers perform the rapid test? * Does the rapid test speed up diagnosis and treatment of syphilis in pregnant people and their sexual partners? Participants will: * Give feedback about why they did or did not want to take the rapid test, and what their experience was taking the test; and * Share information about their health, pregnancy, and syphilis treatment (if applicable).
Recruiting
Has No Placebo
Maternity Centre of HamiltonLaura K Erdman, MD PhD FRCPC
Have you considered Ceftriaxone clinical trials? We made a collection of clinical trials featuring Ceftriaxone, we think they might fit your search criteria.Go to Trials
Image of Public Health Sexual Health Clinic in Seattle, United States.

Doxycycline for Syphilis

18+
All Sexes
Seattle, WA
The goal of this clinical trial is to learn if doxycycline taken as 200mg daily for 14 days is effective to treat early stage syphilis. This is different from how doxycycline is typically used for syphilis because the full doxycycline dose will be taken at the same time of day, rather than split up into a twice daily regimen. Lab data support that taking the medication as a single daily dose should be effective as treatment, but it has not been studied clinically. The main question this study aims to answer is: Is doxycycline taken as a single daily dose of 200mg for 14 days an effective treatment for early syphilis based on a combined outcome of clinical improvement and blood test improvement? Participants will: 1. Take doxycycline 200mg daily for 14 days 2. Submit oral and rectal swabs that test for syphilis bacteria every other day for 2 weeks, returned by mail 3. Complete 2 brief online surveys over the first 2 weeks 4. Return to the clinic for an interview and blood draw every 3 months for a maximum of 3 study visits, including the first visit The investigators will compare the percentage of participants in the study who have response to treatment by 6 months to that of persons who have received standard (CDC-recommended) regimens. To do this, the investigators will calculate response percentage estimates following a shot of long-acting penicillin or 14 days of doxycycline 100mg twice daily from 60-person samples from the sexual health program's records.
Phase 2
Recruiting
Public Health Sexual Health ClinicTravis Hunt, MD
Image of The University of Texas Health Science Center at Houston in Houston, United States.

Rapid POC Testing for Syphilis

18 - 50
Female
Houston, TX
The purpose of this study is to offer routine lab-based and rapid point of care (POC) syphilis diagnostic testing in the emergency department (ED) and obstetrical (OB) triage , thereby increasing screening and treatment initiation for pregnant patients without prenatal care or with no documented syphilis results during the index pregnancy in other to increase rates of full treatment to determine if the implementation of a robust linkage to care program for pregnant patients with positive rapid POC results will more likely result in complete treatment for all stages of syphilis and adherence to recommended maternal and newborn longitudinal follow up and to assess factors that contribute to treatment completion after implementation of the intervention will also be analyzed to tailor efforts targeting social and healthcare navigation factors that affect health equity; including poverty, insurance, health literacy and others.
Waitlist Available
Has No Placebo
The University of Texas Health Science Center at HoustonIrene Stafford, MD
Have you considered Ceftriaxone clinical trials? We made a collection of clinical trials featuring Ceftriaxone, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security